Mass. General team identifies mechanisms behind resistance to FGFR inhibitor drug
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified the first genetic mechanisms conferring acquired resistance to a promising group of targeted cancer drugs. In a paper appearing in the ...
Mar 23, 2017
0
0